Trial Profile
24h BP Under Micardis in Daily Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 14 May 2012 Actual patient number 670 added as reported by ClinicalTrials.gov.
- 24 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 24 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.